Sulfacetamide Sodium And Prednisolone Sodium Phosphate

   
Google
 
Web NewDrugInformation.com

Sulfacetamide Sodium And Prednisolone Sodium Phosphate


Drug - Sulfacetamide Sodium And Prednisolone Sodium Phosphate
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Prednisolone Sodium Phosphate; Sulfacetamide Sodium
Multiple ingredients are in alphabetical order.

Strength - EQ 0.23% PHOSPHATE;10%
The potency of the active ingredient(s), Prednisolone Sodium Phosphate; Sulfacetamide Sodium. May repeat for multiple part products.

Applicant - BAUSCH AND LOMB
The firm name holding legal responsibility for Sulfacetamide Sodium And Prednisolone Sodium Phosphate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 074449
The FDA assigned number to Sulfacetamide Sodium And Prednisolone Sodium Phosphate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Sulfacetamide Sodium And Prednisolone Sodium Phosphate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AT
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 29, 1995
The date Sulfacetamide Sodium And Prednisolone Sodium Phosphate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Sulfacetamide Sodium And Prednisolone Sodium Phosphate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Sulfacetamide Sodium And Prednisolone Sodium Phosphate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bausch And Lomb Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Sulfacetamide Sodium And Prednisolone Sodium Phosphate.

Sulfacetamide Sodium And Prednisolone Sodium Phosphate